These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45. Disparate outcomes from applying U.K. and U.S. osteoporosis treatment guidelines. Bolland MJ; Grey A J Clin Endocrinol Metab; 2010 Apr; 95(4):1856-60. PubMed ID: 20147581 [TBL] [Abstract][Full Text] [Related]
46. A randomized, placebo-controlled trial of calcium supplementation for decreased bone density in corticosteroid-using patients with inflammatory bowel disease: a pilot study. Bernstein CN; Seeger LL; Anton PA; Artinian L; Geffrey S; Goodman W; Belin TR; Shanahan F Aliment Pharmacol Ther; 1996 Oct; 10(5):777-86. PubMed ID: 8899087 [TBL] [Abstract][Full Text] [Related]
50. 2017 American College of Rheumatology Guideline for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis. Buckley L; Guyatt G; Fink HA; Cannon M; Grossman J; Hansen KE; Humphrey MB; Lane NE; Magrey M; Miller M; Morrison L; Rao M; Byun Robinson A; Saha S; Wolver S; Bannuru RR; Vaysbrot E; Osani M; Turgunbaev M; Miller AS; McAlindon T Arthritis Care Res (Hoboken); 2017 Aug; 69(8):1095-1110. PubMed ID: 28585410 [TBL] [Abstract][Full Text] [Related]
52. Advances in the management of corticosteroid-induced osteoporosis with bisphosphonates. Ringe JD; Farahmand P Clin Rheumatol; 2007 Apr; 26(4):474-84. PubMed ID: 17122953 [TBL] [Abstract][Full Text] [Related]
53. Vitamin D analogs versus native vitamin D in preventing bone loss and osteoporosis-related fractures: a comparative meta-analysis. Richy F; Schacht E; Bruyere O; Ethgen O; Gourlay M; Reginster JY Calcif Tissue Int; 2005 Mar; 76(3):176-86. PubMed ID: 15692726 [TBL] [Abstract][Full Text] [Related]
54. Steroid-induced osteoporosis. Sambrook PN Ann Acad Med Singap; 2002 Jan; 31(1):48-53. PubMed ID: 11885496 [TBL] [Abstract][Full Text] [Related]
55. Bone histomorphometry in corticosteroid-induced osteoporosis and Cushing's syndrome. Meunier PJ; Dempster DW; Edouard C; Chapuy MC; Arlot M; Charhon S Adv Exp Med Biol; 1984; 171():191-200. PubMed ID: 6720458 [No Abstract] [Full Text] [Related]
56. A metaanalysis on the use of bisphosphonates in corticosteroid induced osteoporosis. Homik JE; Cranney A; Shea B; Tugwell P; Wells G; Adachi JD; Suarez-Almazor ME J Rheumatol; 1999 May; 26(5):1148-57. PubMed ID: 10332982 [TBL] [Abstract][Full Text] [Related]
57. Osteoporosis in neurological disorders. Lloyd ME; Spector TD; Howard R J Neurol Neurosurg Psychiatry; 2000 May; 68(5):543-7. PubMed ID: 10766878 [No Abstract] [Full Text] [Related]
58. Addressing information needs in the management of osteoporosis. Naunton M; Peterson GM; Jones G Osteoporos Int; 2004 Jun; 15(6):505; author reply 506. PubMed ID: 15103453 [No Abstract] [Full Text] [Related]
59. Eczema is associated with osteoporosis and fractures in adults: a US population-based study. Garg NK; Silverberg JI J Allergy Clin Immunol; 2015 Apr; 135(4):1085-1087.e2. PubMed ID: 25512080 [No Abstract] [Full Text] [Related]
60. Prevention of corticosteroid-induced osteoporosis. Cassim B S Afr Med J; 1997 Mar; 87(3 Suppl):388. PubMed ID: 9137363 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]